Last Published 10.01.2025 Effective Date: 10.01.2025 This policy addresses the use of white blood cell colony stimulating factors (CSFs), including the drug products Fulphila, Fylnetra, Granix, Leukine, Neulasta, Neupogen, Nivestym, Nyvepria, Releuko, Rolvedon, Stimufend, Udenyca, Zarxio, and Ziextenzo
The peptide may also support the health of brain cells by boosting important growth factors like Nerve Growth Factor (NGF) and Brain-Derived Neurotrophic Factor (BDNF) (7)
doi: 10.21037/jtd-cus-2020-012 35
"Data show Lilly's Foundayo and Zepbound were associated with meaningful weight loss in people aged 65 and older, with safety profiles generally consistent with other age groups, reinforcing that these medicines may be effective and appropriate for older adults." Who is eligible for these medicines through the Medicare GLP-1 Bridge program
doi: 10.3390/nu14183705
Dosage: Semaglutide comes in a standard dose of 0.5mg or 1mg once a week, while Tirzepatide has different dosing options ranging from 5mg to 15mg once a week
